Orient Pharma Co., Ltd.
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.oppharma.com
Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
- Conditions
- Interventions
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2022-05-18
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 390
- Registration Number
- NCT04643093
- Locations
- 🇨🇳
E-Da Hospital, Kaohsiung, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
🇨🇳Tri-Service General Hospital, Taipei, Taiwan
Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
- Conditions
- Interventions
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT02704390
- Locations
- 🇨🇳
Chang Gung Medical Foundation- Linkuo Branch, Taoyuan, Taiwan
🇨🇳Chang Gung Medical Foundation- Chiayi Branch, Chiayi City, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis
- Conditions
- Interventions
- First Posted Date
- 2015-06-10
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 557
- Registration Number
- NCT02467608
- Locations
- 🇨🇳
Cheng Hsin General Hospital, Taipei, Taiwan
🇨🇳Taipei Medical University Hospital, Taipei, Taiwan
🇨🇳Chang Gung Memorial Hospital, ChiaYi, Chiayi City, Taiwan
Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
- Conditions
- Interventions
- First Posted Date
- 2015-05-21
- Last Posted Date
- 2021-12-06
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 114
- Registration Number
- NCT02450890
- Locations
- 🇨🇳
Tri-Service General Hospital, Taipei City, Taiwan
🇨🇳Chang Gung Medical Foundation- Chiayi Branch, Chiayi City, Taiwan
🇨🇳Chang Gung Medical Foundation- Linkuo Branch, Taoyuan, Taiwan
Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2023-07-17
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 202
- Registration Number
- NCT01710007
- Locations
- 🇨🇳
Buddhist Taipei TzuChi General Hospital, New Taipei City, Taiwan
🇨🇳Taipei Medical University - Shuang Ho Hospital, New Taipei City, Taiwan
🇨🇳Taichung Veterans General Hospital, Taichung City, Taiwan
A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease
- First Posted Date
- 2011-06-10
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Orient Pharma Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT01370811
- Locations
- 🇺🇸
QUEST Research Institute, Bingham Farms, Michigan, United States